Traditional Chinese medicine combined with hepatic targeted drug delivery systems: A new strategy for the treatment of liver diseases - 31/07/19
, Zhidong Liu a, b, ⁎ Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
| pages | 20 |
| Iconographies | 7 |
| Vidéos | 0 |
| Autres | 0 |
Abstract |
Liver diseases are clinically common and present a substantial public health issue. Many of the currently available drugs for the treatment of liver diseases suffer from limitations that include low hepatic distribution, lack of target effects, poor in vivo stability and adverse effects on other organs. Consequently, conventional treatment of hepatic diseases is ineffective. TCM is commonly used in the treatment of liver diseases worldwide, particularly in China, and has advantages over conventional therapy. HTDDS can be designed to enhance clinical efficacy in the treatment of liver diseases. We have conducted an extensive review of 335 studies reported since 1964. These included about 166 references involving the treatment of liver diseases with TCM (covering active components of TCM, single TCM and Chinese medicine formulas), 169 reports on HTDDS and background studies on liver-related diseases. Here we review the long history of TCM in the treatment of liver diseases.We have also reviewed the status of studies on active components of TCM using nanotechnology-based targeted delivery systems to provide support for further research and development of TCM-based targeted preparations for the treatment of liver disease.
Le texte complet de cet article est disponible en PDF.Abbreviations : ALD, ADRs, APIs, AFP, AD, ASGP-R, BA, BBR, BAE, BEA, CUR, CDDP, DIO, FA, FZHY, GA, GEN, GL, GLR, GAD, GADR, HTDDS, HBV, HCV, HCC, HPCs, HSCs, HCPT, IAN, ISO, ICG, KCs, LUT, LF, Lip, LPNs, LMWH, LA, LDL, LDLR, Mat, MPS, Mic, Mle, MSNs, MMR, MR, M6P/IGF II R, NAFLD, NPs, NCTD, NLCs, NR, OMT, PNPs, PTH, PTX, QE, Rg3, Rb1, Rg1, RES, Sal B, SLNs, SECs, SY, TSIIA, TfR, TCM, UA, WG, WHO, XCHD
Keywords : Traditional Chinese medicine, Hepatic targeted drug delivery system, Nanotechnology, Liver diseases, Natural drug, Chinese herb
Plan
Vol 117
Article 109128- septembre 2019 Retour au numéro
Article précédent
- Natural products for treating colorectal cancer: A mechanistic review
- Xuan-mei Huang, Zhi-jie Yang, Qing Xie, Zi-kang Zhang, Hua Zhang, Jun-ying Ma
- Research progress in the relationship between type 2 diabetes mellitus and intestinal flora
- Quantao Ma, Yaqi Li, Pengfei Li, Min Wang, Jingkang Wang, Ziyan Tang, Ting Wang, Linglong Luo, Chunguo Wang, Ting Wang, Baosheng Zhao
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’achat d’article à l’unité est indisponible à l’heure actuelle.
Déjà abonné à cette revue ?